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This study aimed to determine differences in spinal motoneuron dysfunction between
the abductor pollicis brevis (APB) and the abductor digiti minimi (ADM) in amyotrophic
lateral sclerosis (ALS) patients based on studying F-waves. Forty ALS patients and
20 normal controls (NCs) underwent motor nerve conduction studies on both median
and ulnar nerves, including F-waves elicited by 100 electrical stimuli. The F-wave
persistence (P < 0.05), index repeating neuron (RN; P < 0.001), and index repeater
F-waves (Freps; P < 0.001) significantly differed between the APB and the ADM
in the NC participants. For the hands of the ALS patients that lacked detectable
wasting or weakness and exhibited either no or mild impairment of discrete finger
movements, significantly reduced F-wave persistence (P < 0.001), increased index
RN (P < 0.001), and increased index Freps (P < 0.001) were observed in APB in
comparison with the normal participants, with relatively normal ADM F-wave parameters.
For the hands of ALS patients that exhibited wasting and weakness, the mean
F-wave amplitude (P < 0.05), the F/M amplitude ratio (P < 0.05), F-wave persistence
(P < 0.001), index RN (P < 0.05), and index Freps (P < 0.05) significantly differed
between APB and ADM. The differences in the dysfunction of motoneurons innervating
APB and ADM are unique manifestations in ALS patients. The F-wave persistence
(P = 0.002), index RN (P < 0.001), and index Freps (P < 0.001) in the APB seemed
to differentiate ALS from the NCs more robustly than the ADM/APB Compound
muscle action potential (CMAP) amplitude ratio. Thus, F-waves may reveal subclinical
alterations in anterior horn cells, and may potentially help to distinguish ALS from mimic
disorders.
Keywords: amyotrophic lateral sclerosis, F-wave, abductor pollicis brevis, abductor digiti minimi, motor neuron,
split-hand
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive disorder characterized by the involvement
of both upper and lower motor neurons (UMNs and LMNs). In ALS, muscle wasting
preferentially affects the abductor pollicis brevis (APB) and first dorsal interosseous, with
relative preservation of the abductor digiti minimi (ADM). This specific feature of ALS has
been termed the ‘‘split-hand’’ sign (Wilbourn, 2000). In general, the extent of motor unit loss is
significantly greater in the APB than in the ADM in patients with ALS (Kuwabara et al., 1999).
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Both cortical and peripheral mechanisms have been proposed
to underlie the different levels of atrophy among the small hand
muscles in ALS (Weber et al., 2000; Shibuya et al., 2013). The
findings of transcranial magnetic stimulation studies have shown
that corticomotoneuronal input to the spinal motoneurons
innervating the thenar complex is more extensive in normal
participants (Macdonell et al., 1999; Menon et al., 2014). Such
a difference in inputs might cause these spinal motoneurons
to preferentially degenerate in ALS through a transsynaptic
anterograde excitotoxic mechanism. Corticomotoneuronal
projections to the thenar complex are preferentially affected
in ALS, which suggests that corticomotoneuronal dysfunction
contributes to the split-hand sign in ALS (Weber et al., 2000).
Studies of peripheral nerve excitability have suggested that the
motoneuron axons innervating the APB are hyperexcitable
and prone to degeneration in ALS (Vucic and Kiernan,
2010; Shibuya et al., 2013). However, to date, there are
few studies that have directly compared the dysfunction or
excitability of motoneurons innervating the APB and ADM.
The F-wave is a late and low-amplitude response that reflects
antidromic activation of motoneurons (Pastore-Olmedo et al.,
2009). F-waves may provide an independent measure of
segmental motoneuron excitability (Fisher, 1992; Milanov,
1992; Hachisuka et al., 2015). The primary purpose of this
study was to examine the differences in dysfunction between
spinal motoneurons innervating the APB and ADM in ALS
using F-waves.
MATERIALS AND METHODS
Participants
We studied 40 patients with sporadic ALS and 20 age- and
gender-matched normal participants. All patients were seen
at the Department of Neurology in Peking Union Medical
College Hospital between August 2013 and June 2014. The
ALS patients who met the modified El Escorial criteria
for definite, probable, or probable laboratory-supported ALS
(Brooks et al., 2000) were consecutively enrolled in the study.
Various electrophysiological examinations and clinical features,
such as age at enrollment and the time from symptom onset,
were analyzed in these patients. No genetic mutation had been
identified in any of the ALS patients. UMN involvement in the
upper limbs was suggested by the presence of clonus, increased
tone, brisk tendon reflexes, and positive Hoffman signs. The
ALS patients were assigned two groups based on their physical
symptoms. The patients in group 1 (20 patients with ALS) had
wasting and weakness of the intrinsic hand muscles. The patients
in group 2 (20 patients with ALS) exhibited no wasting or
weakness of the intrinsic hand muscles and showed either no
or mild impairment of discrete finger movements. The data for
the more affected hand were analyzed for the ALS patients in
group 1, whereas, the data for themore intact hand were analyzed
for the ALS patients in group 2. The data for the left hand
were analyzed for the normal controls (NCs). The ALS patients
were clinically staged using the ALS functional rating scale-
revised (ALSFRS-R; Cedarbaum et al., 1999) and categorized
according to the site of disease onset. The electrodiagnostic
features of all ALS patients were consistent with a diffuse and
progressive degeneration of anterior horn cells. At the time of
the investigation, none of the patients were taking riluzole or
other antispasticity drugs. Participants with coincidental carpal
or cubital tunnel syndrome based on clinical examination and
nerve conduction studies were excluded. All subjects provided
informed written consent to participate in the investigation.
The study was approved by the Ethics Committee of Clinical
Research of Peking Union Medical College Hospital (Beijing,
China), and all procedures were conducted in accordance with
the Declaration of Helsinki.
Nerve Conduction Study
The electrophysiological tests were performed using a Viking IV
electromyography (EEG) system (Nicolet Biomedical, Madison,
WI, USA). Compound muscle action potentials (CMAPs) were
recorded from the APB and ADM muscles after median or
ulnar nerve stimulation at the wrist. The skin temperature
for the studied limbs was maintained at >32◦C. The distal
motor latency (DML), peak-to-peak CMAP amplitude, motor
conduction velocity (MCV) and ADM/APB CMAP amplitude
ratio were measured.
F-wave Study
All subjects were supine and relaxed throughout the experiments.
The F-waves of the median and ulnar nerves were recorded
with surface electrodes attached to the skin over the APB and
ADMmuscles. The studied nerves were stimulated by delivering
100 supramaximal stimuli with a frequency of 1 Hz at a site
that was 7 cm proximal to the active recording electrode with
the cathode proximal to the anode. A total of 100 stimuli
were considered appropriate for exploring the full potential of
F-waves (Fisher et al., 1994). The filter settings were 20 Hz to
10 kHz, the sweep speed was 5 ms per division, and the amplifier
gain was 0.5 mV per division. A-waves, which were defined as
identical late responses with constant latencies that occurred
in at least 8 out of 20 traces, were excluded from the F-wave
study (Puksa et al., 2003). The following F-wave parameters
were analyzed: minimal latency, mean latency, maximal latency,
F-wave persistence, mean amplitude, mean F/M amplitude ratio,
and number of repeater F-waves. The peak-to-peak amplitude of
an F-wave was measured if the amplitude was at least 40 µV.
The mean F/M amplitude ratio was calculated by dividing the
mean F-wave amplitude by the corresponding maximal CMAP
amplitude. A repeating neuron (RN) was a neuron that gave
rise to a series of F-waves with identical latencies, amplitudes,
and shapes, and these F-waves were defined as repeater F-waves.
RNs and repeater F-waves were detected via visual inspection
and were manually superimposed on the other repeater F-waves.
The repeater F-waves were measured using the following indices:
index RN = 100 × number of RN/number of traces with
different F-wave shapes in a series of 100 stimuli; index repeater
F-waves (Freps) = 100 × number of repeater F-waves/total
number of traces with F-waves in the same nerve (Chroni et al.,
2012).
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Statistical Analyses
The Shapiro–Wilk test was used to assess the normality of the
data. When the P-value in the analysis of variance achieved
significance, the Student–Newman–Keuls test was performed.
The independent-sample t-test was used to assess differences
between two groups. For non-parametric data, comparisons
between groups were performed using the Kruskal–WallisH test.
Once the null hypothesis was rejected, pairwise comparisons of
the groups were tested using the Mann–Whitney U test and
Bonferroni correction with a significance level of P < 0.017.
The differences in categorical variables were examined by the
Chi-square test. The statistical significance was set at P < 0.05.
SPSS for Windows, version 21.0 (SPSS, Inc., Chicago, IL, USA),
was used to perform the statistical analyses.
RESULTS
The clinical profiles of the ALS patients and the NC participants
are summarized in Table 1. All the ALS patients were clinically
LMN-predominant. The age at examination, gender ratio and
height were comparable across the three groups. Among the
ALS patients, upper limb-onset disease accounted for 70% of
the patients in group 1 and 25% of the patients in group 2.
There were 11 ALS patients in group 1 and 10 in group 2 with
two affected body regions, and there were 9 generalized patients
in group 1 and 10 in group 2. The disease duration and
the ALSFRS-R scores did not differ significantly between the
ALS patients in groups 1 and 2.
Table 2 shows the results of the nerve conduction study for
the ALS patients and the NCs. The ADM/APB CMAP amplitude
ratio was significantly increased in the ALS patients in group 1
compared with the NC group, which was observed consistently
with the split-hand sign in ALS patients (Kuwabara et al., 2008).
The results of the F-wave study for the ALS patients and NCs
are shown in Table 3. The mean F-wave amplitude for the
APB was significantly lower in group 1 than in group 2, which
were comparable between group 2 and the NCs. The mean
F-wave amplitudes of the ADM in groups 1 and 2 were
significantly increased compared to that in the NCs. The F/M
amplitude ratios of the APB and ADM in group 1 were
significantly higher than those in group 2 and NCs, whereas
group 2 and NCs showed similar F/M amplitude ratios. The
F-wave persistence of the APB, which was significantly lower
in the ALS patients than in NCs, was comparable between
groups 1 and 2. The F-wave persistence of the ADM was
significantly lower in group 1 than in group 2 and NCs,
whereas the F-wave persistence of the ADM was similar between
group 2 and NCs. The index RN and index Freps of APB were
significantly increased in groups 1 and 2 compared with the
NCs, but these indices were comparable between groups 1 and 2.
The index RN and index Freps of the ADM was significantly
higher in group 1 than in group 2 and the NCs, whereas
group 2 and NCs showed similar values for these indices.
Figure 1 presents representative examples of F-wave traces for
the median and the ulnar nerves recorded from ALS patients in
groups 1, 2 and NCs.
Table 4 shows the diagnostic performance of the F-wave in
ALS vs. NCs. The F-wave could be used to help differentiate
ALS patients from NCs. The index RN and index Freps of
the APB appeared to be reliable variables for differentiating
ALS patients from NCs, as the area under the curve (AUC)
for the index RN (0.998, 95% confidence interval (CI)
0.937–1.000) and index Freps (1.000, 95% CI 0.940–1.000)
showed ‘‘very good’’ diagnostic utility. The remainder of the
F-wave variables had lower AUC values than the index RN
and index Freps of the APB and thus showed less diagnostic
utility. The ADM/APB CMAP amplitude ratio showed an
AUC of 0.766 (95% CI 0.638–0.865, P < 0.001) and could
moderately differentiate ALS patients from NCs. Using a
cut-off value of ADM/APB > 1.7 (Kim et al., 2015) for
diagnosing ALS yielded a moderate sensitivity (52.5%) and a
high specificity (85.0%) compared with controls. The F-wave
persistence (P = 0.002), index RN (P < 0.001) and index Freps
(P < 0.001) in the APB appeared to differentiate ALS patients
from NCs more robustly than the ADM/APB CMAP amplitude
ratio.
DISCUSSION
The primary aim of this study was to use F-wave measures
to ascertain the differences in dysfunction between APB and
ADM motoneurons in patients with ALS. According to a
TABLE 1 | Clinical profiles of the participants.
Parameters Group 1 Group 2 NC P-value P-value P-value
Group1 vs. NC Group 2 vs. NC Groups 1 vs. 2
Age 47.15 ± 9.56 49.6 ± 8.93 50.9 ± 10.86 0.461 0.862 0.445
[years ± SD (range)] (28–68) (33–65) (35–65)
Gender (male: female) 16:4 12:8 12:8 0.168 1 0.168
Disease duration 14.30 ± 6.59 15.10 ± 15.77 NA NA NA 0.343
[months ± SD (range)] (6–26) (3–72)
Height (cm) 169.35 ± 6.49 168.9 ± 6.54 167.65 ± 7.71 >0.05 >0.05 >0.05
ALSFRS-R score 38.20 ± 6.65 40.30 ± 3.33 NA NA NA 0.478
[mean ± SD (range)] (17–44) (34–45)
ALSFRS-R, amyotrophic lateral sclerosis functional rating scale-revised; NA, not applicable; NC, normal control; SD, standard deviation. All data are expressed as
mean ± SD.
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TABLE 2 | Results of nerve conduction study.
Parameters Group 1 Group 2 NC P-value P-value P-value
Group 1 vs. NC Group 2 vs. NC Groups 1 vs. 2
DML (ms)
APB 3.71 (0.78)∗ 3.17 (0.40)∗ 2.93 (0.41)∗ <0.001 0.028 <0.001
ADM 2.46 (0.46)∗ 2.29 (0.31)∗ 2.15 (0.29)∗ 0.002 0.142 0.301
CMAP amplitude (mV)
APB 2.85 (1.39)∗ 11.76 (2.84) 12.44 (3.21) <0.05 >0.05 <0.05
ADM 8.34 (2.58)∗ 13.25 (2.46) 13.76 (2.31) <0.05 >0.05 <0.05
ADM/APB ratio 3.74 (2.56) 1.12 (0.28) 1.12 (0.39) <0.001 0.620 <0.001
MCV (m/s)
APB 55.56 (5.78) 56.99 (5.58) 57.13 (5.98) >0.05 >0.05 >0.05
ADM 56.53 (6.87) 58.35 (6.78) 56.33 (3.51) >0.05 >0.05 >0.05
ADM, abductor digiti minimi; ALS, amyotrophic lateral sclerosis; APB, abductor pollicis brevis; ADM/APB ratio, ADM/APB CMAP amplitude ratio; CMAP, compound
muscle action potential; DML, distal motor latency; MCV, motor conduction velocity; NC, normal control. All data are expressed as mean (SD). Values with significant
differences printed in bold characters. ∗P < 0.001, between the APB and the ADM in each group. For comparisons of DML and ADM/APB ratio between the ALS patients
in groups 1 and 2, and the normal controls, Bonferroni correction with a level of significance of <0.017 was used.
proposed staging system for ALS (Roche et al., 2012), the
stages of the disease were comparable between groups 1 and 2.
The difference in the percentage of upper limb onset between
groups 1 and 2 may underlie a different pattern of disease
progression between the two groups. The estimated number
of motor units and CMAP amplitudes are useful parameters
for evaluating motoneuron loss, whereas the F-wave may be
a direct probe of dysfunction or instability in anterior horn
cells (Hachisuka et al., 2015). The F-wave persistence is related
to the number of LMNs and motoneuron excitability (Schiller
and Stalberg, 1978; de Carvalho et al., 2002; Argyriou et al.,
2006). The proposed mechanisms underlying repeater F-waves
are increased excitability in particular anterior horn cells,
decreased excitability in some motoneurons, or motoneuron
loss (Schiller and Stalberg, 1978; Petajan, 1985; Peioglou-
Harmoussi et al., 1987; Hachisuka et al., 2015). As motoneurons
are lost, repeater F-waves from individual motoneurons may
be recognized more easily; however, it has been argued that
TABLE 3 | F-wave study in the ALS patients and the normal controls.
Group 1 Group 2 NC P-value P-value P-value
Group 1 vs. NC Group 2 vs. NC Groups 1 vs. 2
Minimal F latency (ms)
APB 25.61 (3.17) 24.55 (1.86) 23.89 (1.53) >0.05 >0.05 >0.05
ADM 25.85 (2.21) 24.54 (1.55) 24.06 (1.89) <0.05 >0.05 <0.05
Maximal F latency (ms)
APB 29.98 (2.64) 28.74 (1.87) 26.94 (1.81) <0.05 <0.05 >0.05
ADM 30.18 (2.31) 27.99 (2.02) 26.77 (2.04) <0.05 >0.05 <0.05
Mean F latency (ms)
APB 27.77 (2.43) 26.14 (1.67) 25.23 (1.65) <0.05 >0.05 <0.05
ADM 27.45 (2.27) 25.99 (1.67) 25.26 (1.97) <0.05 >0.05 <0.05
Mean F amplitude (µV)
APB 263.05 (287.06)∗∗ 342.75 (164.99) 262.70 (91.83) >0.05 >0.05 <0.05
ADM 375.90 (146.46)∗∗ 350.20 (118.38) 267.40 (78.83) <0.05 <0.05 >0.05
F/M amplitude ratio
APB 13.35 (19.76)∗∗ 3.15 (1.95) 2.15 (0.74) <0.001 0.063 <0.001
ADM 4.85 (2.54)∗∗ 2.71 (1.07) 2.01 (0.74) <0.001 0.020 <0.001
F-wave persistence (%)
APB 39.35 (27.76)∗ 51.00 (17.45)∗ 95.40 (4.90)∗∗ <0.001 <0.001 0.076
ADM 78.70 (23.32)∗ 98.10 (3.39)∗ 99.25 (1.45)∗∗ <0.001 0.327 <0.001
Index RN (%)
APB 41.89 (26.09)∗∗ 31.87 (17.47)∗ 3.44 (2.98)∗ <0.001 <0.001 0.277
ADM 25.26 (16.59)∗∗ 2.19 (5.44)∗ 0.70 (1.59)∗ <0.001 0.157 <0.001
Index Freps (%)
APB 72.50 (23.43)∗∗ 62.65 (18.86)∗ 7.07 (6.16)∗ <0.001 <0.001 0.134
ADM 51.27 (30.09)∗∗ 4.67 (11.19)∗ 1.39 (3.19)∗ <0.001 0.149 <0.001
APB, abductor pollicis brevis; ADM, abductor digiti minimi; NC, normal control. All data are expressed as mean (SD). Values with significant differences printed in bold
characters. ∗P < 0.001, ∗∗P < 0.05, between the APB and the ADM in each group. For comparisons of F/M amplitude ratio, F-wave persistence, index RN, and index
Freps between the ALS patients in groups 1 and 2, and the normal controls, Bonferroni correction with a level of significance of <0.017 was used.
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FIGURE 1 | Representative examples of F-waves recorded from the amyotrophic lateral sclerosis (ALS) patients and the normal controls (NCs).
(A) F-waves recorded from an ALS patient hand exhibiting wasting and weakness. Reduced F-wave persistence and increased number of repeater F-waves were
observed on F-waves recorded from both the median and ulnar nerves. (B) F-waves recorded from an ALS patient hand lacking detectable wasting or weakness.
The F-wave persistence was reduced and the number of repeater F-waves was increased on the median nerve, while parameters of F-waves recorded from the
ulnar nerve were relatively normal. (C) F-waves recorded from a healthy subject on the left upper limb. F-wave amplitudes, latencies and waveforms were variable,
and F-wave persistence was normal on both the median and ulnar nerves. Letters to the right of record identify repeater F-waves on the basis of amplitude, latency
and waveform. Calibrations are 0.5 mV and 5 ms for F-wave recording.
the low frequency of backfiring of individual motoneurons
makes the mechanism rather unlikely (Chroni et al., 2012).
Physiologically, there were significant differences in the F-wave
persistence and the number of repeater F-waves between the
APB and ADM. These findings may be associated with a
lower number of functional motoneurons innvervating the APB
(Gooch et al., 2014), or increased cortical inhibitory modulation
of the APB (Menon et al., 2014).
In ALS, dysfunction of spinal motoneurons develops
gradually before the onset of overt symptoms (Bradley, 1987).
In the present study, the ALS patients who lacked detectable
wasting or weakness in the hands showed significantly reduced
TABLE 4 | Diagnostic performance of F-wave in amyotrophic lateral sclerosis (ALS) vs. normal controls (NCs).
Parameters Cut-off value Sensitivity (%) Specificity (%) AUC (95% CI)
APB
Minimal F latency 24.55 ms 60.0 75.0 0.646 (0.505–0.787) P = 0.068
Maximal F latency 28.30 ms 70.0 75.0 0.792 (0.678–0.906) P < 0.001
Mean F amplitude 260.00 µV 62.5 55.0 0.526 (0.393–0.656) P = 0.738
F/M amplitude ratio 2.60 72.5 85.0 0.820 (0.699–0.907) P < 0.001
F persistence 81.00% 95.0 100.0 0.976 (0.898–0.998) P < 0.001
Index RN 9.64% 97.5 100.0 0.998 (0.937–1.000) P < 0.001
Index Freps 19.35% 100.0 100.0 1.000 (0.940–1.000) P < 0.001
ADM
Minimal F latency 22.80 ms 92.5 35.0 0.664 (0.530–0.781) P = 0.034
Maximal F latency 26.70 ms 85.0 65.0 0.769 (0.642–0.868) P < 0.001
Mean F latency 26.70 ms 65.0 70.0 0.695 (0.563–0.807) P = 0.011
Mean F amplitude 320.00 µV 57.5 85.0 0.716 (0.585–0.825) P = 0.001
F/M amplitude ratio 2.66 62.5 90.0 0.819 (0.699–0.907) P < 0.001
F persistence 97.00% 55.0 95.0 0.750 (0.621–0.853) P < 0.001
Index RN 0.00% 75.0 80.0 0.804 (0.681–0.895) P < 0.001
Index Freps 0.00% 75.0 80.0 0.805 (0.682–0.896) P < 0.001
APB, abductor pollicis brevis; ADM, abductor digiti minimi; AUC, area under the curve; CI, confidence interval.
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F-wave persistence and higher index RN and index Freps
values for the APB compared with those of NCs. Furthermore,
these ALS patients showed relatively normal F-wave values
in the ADM. These data are consistent with a preferential
dysfunction of spinal motoneurons innervating the APB in
ALS (Baumann et al., 2012). In ALS, however, the spinal
motoneurons innervating the APB may be more active than
those innervating the ADM, and the CMAP amplitude may
not have sufficient sensitivity for detecting motoneuron loss
because the remaining motoneurons may provide compensatory
collateral reinnervation of denervated muscle fibers (van Dijk
et al., 2010). Analyzing F-waves, especially F-waves in the median
nerves, could help to detect subtle alterations of anterior horn
cells even in ALS patients without clinical symptoms and thus
may provide a helpful approach for evaluating the disease
progression.
LMN damage has been shown to reduce the amplitude of
F-waves (Fisher, 1992). Muscle atrophy may lead to a weaker
muscle response by partially neutralizing the hyperexcitability
of the motoneuron pool (Drory et al., 1993). In the present
study, the ALS patients who presented with the split-hand
sign showed significantly reduced F-wave amplitudes, reduced
F-wave persistence, and an increased number of repeater F-waves
in the APB compared with the ADM, which likely reflects
more severe damage to the spinal motoneurons innervating the
APB. The formation of large post-reinnervation motor units
could contribute to increases in the F-wave amplitude (Drory
et al., 2001). A significantly increased F-wave amplitude in the
ADM compared with the APB in the ALS patients is consistent
with a slower motoneuron loss in the ADM motoneuron pool
(Baumann et al., 2012). The F/M amplitude ratio quantifies the
proportion of the motoneuron pool that is activated during
a series of F-waves (Drory et al., 2001). The significantly
increased F/M amplitude ratio in the APB compared with that
in the ADM of ALS patients reflects an increased tendency
of the motoneurons innervating the APB to generate F-waves.
Conversely, the combination of the decreased mean F-wave
amplitude and the increased F/M amplitude ratio in the APB
emphasizes the preferential involvement of the APB in ALS.
Repeater F-waves indicate pathological changes in motor units
(Hachisuka et al., 2015). The significant increase in the number
of repeater F-waves in the APB may imply a greater degree of
hyperexcitability within the spinal motoneurons innervating the
APB (Fang et al., 2015).
Intriguingly, ALS patients who lacked detectable hand muscle
atrophy showed a mean F-wave amplitude for the APB that
was significantly higher than that for the ALS patients who
presented with the split-hand sign. However, the mean F-wave
amplitude for the ADM was comparable between the two ALS
patient groups, regardless of hand muscle atrophy, but was
significantly higher in the ALS patients than in the NCs. The
differences in the F-wave characteristics between the APB and
ADMmay be attributed to the competing effects of degeneration
and regeneration within the motor unit. With the degeneration
of motor neurons, the surviving motor neurons compensate
by reinnervating the denervated muscle fibers through axonal
sprouting (Ibrahim and el-Abd, 1997). In ALS, the denervation
process may begin earlier and progress more rapidly in the thenar
region. The rate of degeneration was slower in the motoneurons
innervating the ADM than in those innervating the APB. Further
studies are necessary to elucidate the mechanisms in ALS that
contribute to the differences inmotoneuron dysfunction between
motoneurons innervating the APB and ADM. We suspected
that cortical mechanisms, peripheral axonal mechanisms, or
spinal segmental dysfunction, particularly in spinal inhibitory
circuits, might contribute to the preferential degeneration of
spinal motoneurons innervating the APB (Turner and Kiernan,
2012; Ramírez-Jarquín et al., 2014).
Previous research demonstrated that the split-hand sign is
more frequently observed in ALS, and the increased ADM/APB
CMAP amplitude ratio is nearly specific to ALS. The present
study demonstrated that the neurophysiological criterion for
the ADM/APB of a CMAP amplitude ratio >1.7 (Kuwabara
et al., 2008) has a moderate sensitivity and high specificity in
differentiating ALS from NCs, which is consistent with previous
studies (Kim et al., 2015). In this study, F-wave parameters
could help to reliably differentiate ALS patients from the normal
participants. Furthermore, the F-wave persistence, index RN and
index Freps in the APB could reliably differentiate ALS patients
from the NCs, as these measures showed larger AUC values than
did the ADM/APB CMAP amplitude ratio.
Our analysis has several limitations. This was a cross-
sectional study, and a relatively small number of participants
were included. A follow-up study with a larger population
is necessary to specifically determine the extent of spinal
dysfunction associated with the split-hand sign in ALS. Another
potential limitation is the lack of a patient control group
consisting of patients with syndromes that mimic ALS. Such a
group would be useful to assess the clinical value of the F-wave in
discriminating ALS from disorders that mimic ALS. Moreover,
further electrophysiological studies that use the methods for
evaluating UMN dysfunction, as well as the excitability of the
motor axons, should be performed on the same patient groups
to shed more light on the pathophysiology of this phenomenon.
In conclusion, our findings demonstrate differences in F-wave
characteristics between the APB and ADM in patients with ALS.
These alterations in the F-waves are characteristic of ALS patients
andmay be helpful for differentiating ALS from certain disorders
that mimic ALS. Elucidating the pathophysiological mechanisms
underlying the differing levels of atrophy in the small hand
muscles would shed light on the pathogenesis of ALS.
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